Non-small cell lung cancer
Conditions
Interventions
experimental group:endostatin
control group:No
Sponsors
The Affiliated Hospital of Jiangnan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with advanced NSCLC confirmed by cytology or histology (patients who do not receive a separate sputum cytology diagnosis); 2. According to the 8th edition of the lung cancer staging system (TNM staging) TNM new staging is judged to be stage IIIB or stage IV 3. It must have at least one evaluable lesion (at least 10mm in the longest diameter on enhanced CT) judged according to the RRECIST version 1.1 standard; 4. Male or female, aged 18 to 75 years; 5. ECOG PS 0-1; 6. The expected survival period is >=3 months; 7. White blood cells > 3.0x10^9/L, platelets > 75x10^9/L, hemoglobin (HB) >= 90g/L; 8. Liver and kidney function are normal; 9. The electrocardiogram is basically normal, and there is no unhealed wound on the body 28 days before the operation; 10. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Combined with mental illness; 2. Women during pregnancy or breastfeeding 3. Those with bleeding tendency; 4. The investigator believes that the patient should not participate in other situations in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival;Overall efficiency;Safety; | — |
Countries
China
Contacts
Public ContactChen Xiaoping
The Affiliated Hospital of Jiangnan University
Outcome results
None listed